References
Leite MI, Jones M, Ströbel P, et al. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol. 2007;171:893–905.
Cavalcante P, Bernasconi P, Mantegazza R. Autoimmune mechanisms in myasthenia gravis. Curr Opin Neurol. 2012;25:621–9.
Lefeuvre CM, Payet CA, Fayet OM, et al. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers. J Autoimmun. 2020;106:102337.
Gong L, Li Y, Li X, et al. Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis. Clin Microbiol Infect. 2019;25:109.e7-e12.
Gong L, Tian J, Zhang Y, et al. Gaosheng Huang. Human parvovirus B19 may be a risk factor in myasthenia gravis with thymoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12936-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have declared no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gong, L., Tian, J., Zhang, W. et al. ASO Author Reflections: A Possible New Etiology of Thymoma-Associated Myasthenia Gravis—Human Parvovirus B19. Ann Surg Oncol 30, 1656–1657 (2023). https://doi.org/10.1245/s10434-022-12958-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12958-3